Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1033

1.

Exposure-response analyses of abiraterone and its metabolites in real-world patients with metastatic castration-resistant prostate cancer.

van Nuland M, Groenland SL, Bergman AM, Steeghs N, Rosing H, Venekamp N, Huitema ADR, Beijnen JH.

Prostate Cancer Prostatic Dis. 2019 Oct 14. doi: 10.1038/s41391-019-0179-5. [Epub ahead of print]

PMID:
31611636
2.

Real-world Outcomes of Sequential Androgen-receptor Targeting Therapies with or Without Interposed Life-prolonging Drugs in Metastatic Castration-resistant Prostate Cancer: Results from the Dutch Castration-resistant Prostate Cancer Registry.

Kuppen MCP, Westgeest HM, van den Eertwegh AJM, van Moorselaar RJA, van Oort IM, Coenen JLLM, van den Bergh ACMF, Mehra N, Somford DM, Bergman AM, Ten Bokkel Huinink D, Fossion L, Geenen MM, Hendriks MP, van de Luijtgaarden ACM, Polee MB, Weijl NI, van de Wouw AJ, de Wit R, Uyl-de Groot CA, Gerritsen WR.

Eur Urol Oncol. 2019 Oct 7. pii: S2588-9311(19)30146-4. doi: 10.1016/j.euo.2019.09.005. [Epub ahead of print]

PMID:
31601523
3.

Exposure-Response Assessment of Enzalutamide and Its Major Metabolites in a Real-World Cohort of Patients with Metastatic Castration-Resistant Prostate Cancer.

van Nuland M, Bergman AM, Rosing H, de Vries N, Huitema ADR, Beijnen JH.

Pharmacotherapy. 2019 Oct 9. doi: 10.1002/phar.2339. [Epub ahead of print]

PMID:
31596947
4.

Surface acoustic wave photonic devices in silicon on insulator.

Munk D, Katzman M, Hen M, Priel M, Feldberg M, Sharabani T, Levy S, Bergman A, Zadok A.

Nat Commun. 2019 Sep 16;10(1):4214. doi: 10.1038/s41467-019-12157-x.

5.

Ensuring the Safety of Chronically Ill Veterans Enrolled in Home-Based Primary Care.

Katzburg J, Wilson D, Fickel J, Lind JD, Cowper-Ripley D, Fleming M, Ong MK, Bergman AA, Bradley SE, Tubbesing SA.

Prev Chronic Dis. 2019 Sep 5;16:E122. doi: 10.5888/pcd16.180501. No abstract available.

6.

The prevalence and impact of lysogeny among oral isolates of Enterococcus faecalis.

Stevens RH, Zhang H, Sedgley C, Bergman A, Manda AR.

J Oral Microbiol. 2019 Jul 25;11(1):1643207. doi: 10.1080/20002297.2019.1643207. eCollection 2019.

7.

Cardiac death after breast radiotherapy and the QUANTEC cardiac guidelines.

Beaton L, Bergman A, Nichol A, Aparicio M, Wong G, Gondara L, Speers C, Weir L, Davis M, Tyldesley S.

Clin Transl Radiat Oncol. 2019 Aug 13;19:39-45. doi: 10.1016/j.ctro.2019.08.001. eCollection 2019 Nov.

8.

Second-Line Cabazitaxel Treatment in Castration-Resistant Prostate Cancer Clinical Trials Compared to Standard of Care in CAPRI: Observational Study in the Netherlands.

Westgeest HM, Kuppen MCP, van den Eertwegh AJM, de Wit R, Coenen JLLM, van den Berg HPP, Mehra N, van Oort IM, Fossion LMCL, Hendriks MP, Bloemendal HJ, van de Luijtgaarden ACM, Ten Bokkel Huinink D, van den Bergh ACMF, van den Bosch J, Polee MB, Weijl N, Bergman AM, Uyl-de Groot CA, Gerritsen WR.

Clin Genitourin Cancer. 2019 Oct;17(5):e946-e956. doi: 10.1016/j.clgc.2019.05.018. Epub 2019 May 31.

PMID:
31439536
9.

Correction to: Chlorinated and brominated organic pollutants in shellfish from the Yellow Sea and East China Sea.

Yin G, Asplund L, Qiu Y, Zhou Y, Wang H, Yao Z, Jiang J, Bergman Å.

Environ Sci Pollut Res Int. 2019 Aug 5. doi: 10.1007/s11356-019-05987-1. [Epub ahead of print]

PMID:
31385243
10.

Correction to: Occurrence and risk assessment of trace metals and metalloids in sediments and benthic invertebrates from Dianshan Lake, China.

Wu Y, Zhou Y, Qiu Y, Chen D, Zhu Z, Zhao J, Bergman Å.

Environ Sci Pollut Res Int. 2019 Sep;26(26):27551. doi: 10.1007/s11356-019-05985-3.

PMID:
31346942
11.

Organophosphate flame retardants in heron eggs from upper Yangtze River basin, southwest China.

Huang Q, Wei L, Bignert A, Ye H, Huang F, Qiu Y, Bergman Å.

Chemosphere. 2019 Dec;236:124327. doi: 10.1016/j.chemosphere.2019.07.058. Epub 2019 Jul 10.

12.

Gender Differences in Veterans' Perceptions of Harassment on Veterans Health Administration Grounds.

Dyer KE, Potter SJ, Hamilton AB, Luger TM, Bergman AA, Yano EM, Klap R.

Womens Health Issues. 2019 Jun 25;29 Suppl 1:S83-S93. doi: 10.1016/j.whi.2019.04.016.

PMID:
31253247
13.

Efficacy, Tolerance, and Plasma Levels of Abiraterone and Its Main Metabolites in a Patient With Metastatic Castration-resistant Prostate Cancer With a Hepatic Transplant.

van Nuland M, Janssen JM, van Hoek B, Rosing H, Beijnen JH, Bergman AM.

Clin Genitourin Cancer. 2019 Oct;17(5):e893-e896. doi: 10.1016/j.clgc.2019.05.026. Epub 2019 May 30. No abstract available.

PMID:
31248829
14.

CHD1 Loss Alters AR Binding at Lineage-Specific Enhancers and Modulates Distinct Transcriptional Programs to Drive Prostate Tumorigenesis.

Augello MA, Liu D, Deonarine LD, Robinson BD, Huang D, Stelloo S, Blattner M, Doane AS, Wong EWP, Chen Y, Rubin MA, Beltran H, Elemento O, Bergman AM, Zwart W, Sboner A, Dephoure N, Barbieri CE.

Cancer Cell. 2019 May 13;35(5):817-819. doi: 10.1016/j.ccell.2019.04.012. No abstract available.

PMID:
31085180
15.

Primary Care Providers' Perspectives on Providing Care to Women Veterans with Histories of Sexual Trauma.

Bergman AA, Hamilton AB, Chrystal JG, Bean-Mayberry BA, Yano EM.

Womens Health Issues. 2019 Jul - Aug;29(4):325-332. doi: 10.1016/j.whi.2019.03.001. Epub 2019 Apr 23.

PMID:
31027706
16.

Mutation of the ATPase Domain of MutS Homolog-5 (MSH5) Reveals a Requirement for a Functional MutSγ Complex for All Crossovers in Mammalian Meiosis.

Milano CR, Holloway JK, Zhang Y, Jin B, Smith C, Bergman A, Edelmann W, Cohen PE.

G3 (Bethesda). 2019 Jun 5;9(6):1839-1850. doi: 10.1534/g3.119.400074.

17.

CHD1 Loss Alters AR Binding at Lineage-Specific Enhancers and Modulates Distinct Transcriptional Programs to Drive Prostate Tumorigenesis.

Augello MA, Liu D, Deonarine LD, Robinson BD, Huang D, Stelloo S, Blattner M, Doane AS, Wong EWP, Chen Y, Rubin MA, Beltran H, Elemento O, Bergman AM, Zwart W, Sboner A, Dephoure N, Barbieri CE.

Cancer Cell. 2019 Apr 15;35(4):603-617.e8. doi: 10.1016/j.ccell.2019.03.001. Epub 2019 Mar 28. Erratum in: Cancer Cell. 2019 May 13;35(5):817-819.

PMID:
30930119
18.

Effects of overexpression of STB5 in Saccharomyces cerevisiae on fatty acid biosynthesis, physiology and transcriptome.

Bergman A, Vitay D, Hellgren J, Chen Y, Nielsen J, Siewers V.

FEMS Yeast Res. 2019 May 1;19(3). pii: foz027. doi: 10.1093/femsyr/foz027.

19.

Effect of Hepatic Organic Anion-Transporting Polypeptide 1B Inhibition and Chronic Kidney Disease on the Pharmacokinetics of a Liver-Targeted Glucokinase Activator: A Model-Based Evaluation.

Bergman A, Bi YA, Mathialagan S, Litchfield J, Kazierad DJ, Pfefferkorn JA, Varma MVS.

Clin Pharmacol Ther. 2019 Oct;106(4):792-802. doi: 10.1002/cpt.1419. Epub 2019 Apr 8.

PMID:
30919935
20.

Androgen receptor enhancer usage and the chromatin regulatory landscape in human prostate cancers.

Stelloo S, Bergman AM, Zwart W.

Endocr Relat Cancer. 2019 Mar 1. pii: ERC-19-0032.R1. doi: 10.1530/ERC-19-0032. [Epub ahead of print] Review.

PMID:
30865928
21.

Assessment of Simplified Methods for Quantification of 18F-FDHT Uptake in Patients with Metastatic Castration-Resistant Prostate Cancer.

Kramer GM, Yaqub M, Vargas HA, Schuit RC, Windhorst AD, van den Eertwegh AJM, van der Veldt AAM, Bergman AM, Burnazi EM, Lewis JS, Chua S, Staton KD, Beattie BJ, Humm JL, Davis ID, Weickhardt AJ, Scott AM, Morris MJ, Hoekstra OS, Lammertsma AA.

J Nucl Med. 2019 Sep;60(9):1221-1227. doi: 10.2967/jnumed.118.220111. Epub 2019 Mar 8.

PMID:
30850488
22.

Neutropenia and docetaxel exposure in metastatic castration-resistant prostate cancer patients: A meta-analysis and evaluation of a clinical cohort.

de Vries Schultink AHM, Crombag MBS, van Werkhoven E, Otten HM, Bergman AM, Schellens JHM, Huitema ADR, Beijnen JH.

Cancer Med. 2019 Apr;8(4):1406-1415. doi: 10.1002/cam4.2003. Epub 2019 Feb 22.

23.
24.

Age-Associated Hematological Toxicity in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Docetaxel in Clinical Practice.

Crombag MBS, de Vries Schultink AHM, van Doremalen JGC, Otten HM, Bergman AM, Schellens JHM, Beijnen JH, Huitema ADR.

Drugs Aging. 2019 Apr;36(4):379-385. doi: 10.1007/s40266-019-00643-2.

PMID:
30734241
25.

Heterologous phosphoketolase expression redirects flux towards acetate, perturbs sugar phosphate pools and increases respiratory demand in Saccharomyces cerevisiae.

Bergman A, Hellgren J, Moritz T, Siewers V, Nielsen J, Chen Y.

Microb Cell Fact. 2019 Feb 1;18(1):25. doi: 10.1186/s12934-019-1072-6.

26.

Frequent clonal relations between metastases and non-index prostate cancer lesions.

Kneppers J, Krijgsman O, Melis M, de Jong J, Peeper DS, Bekers E, van der Poel HG, Zwart W, Bergman AM.

JCI Insight. 2019 Jan 24;4(2). pii: 124756. doi: 10.1172/jci.insight.124756. [Epub ahead of print]

27.

Plasma Levels of Enzalutamide and Its Main Metabolites in a Patient With Metastatic Castration-resistant Prostate Cancer Undergoing Hemodialysis.

van Nuland M, Groenland S, Bergman AM, Rotmans JI, Rosing H, Beijnen JH, Huitema ADR.

Clin Genitourin Cancer. 2019 Apr;17(2):e383-e386. doi: 10.1016/j.clgc.2018.12.004. Epub 2018 Dec 19. No abstract available.

28.

Optimized ChIP-seq method facilitates transcription factor profiling in human tumors.

Singh AA, Schuurman K, Nevedomskaya E, Stelloo S, Linder S, Droog M, Kim Y, Sanders J, van der Poel H, Bergman AM, Wessels LF, Zwart W.

Life Sci Alliance. 2018 Dec 28;2(1):e201800115. doi: 10.26508/lsa.201800115. eCollection 2019 Feb.

29.

HLA class II expression on tumor cells and low numbers of tumor-associated macrophages predict clinical outcome in oropharyngeal cancer.

Cioni B, Jordanova ES, Hooijberg E, van der Linden R, de Menezes RX, Tan K, Willems S, Elbers JBW, Broeks A, Bergman AM, Zuur CL, de Boer JP.

Head Neck. 2019 Feb;41(2):463-478. doi: 10.1002/hed.25442. Epub 2018 Dec 14.

30.

Nationwide reconnaissance of five parabens, triclosan, triclocarban and its transformation products in sewage sludge from China.

Chen J, Meng XZ, Bergman A, Halden RU.

J Hazard Mater. 2019 Mar 5;365:502-510. doi: 10.1016/j.jhazmat.2018.11.021. Epub 2018 Nov 12.

PMID:
30466048
31.

Integrative epigenetic taxonomy of primary prostate cancer.

Stelloo S, Nevedomskaya E, Kim Y, Schuurman K, Valle-Encinas E, Lobo J, Krijgsman O, Peeper DS, Chang SL, Feng FY, Wessels LFA, Henrique R, Jerónimo C, Bergman AM, Zwart W.

Nat Commun. 2018 Nov 21;9(1):4900. doi: 10.1038/s41467-018-07270-2.

32.

Enzalutamide therapy for advanced prostate cancer: efficacy, resistance and beyond

Linder S, van der Poel HG, Bergman AM, Zwart W, Prekovic S.

Endocr Relat Cancer. 2018 Oct 31;26(1):R31-R52. doi: 10.1530/ERC-18-0289.

33.

Re-irradiation volumetric modulated arc therapy optimization based on cumulative biologically effective dose objectives.

McVicar N, Thomas S, Liu M, Carolan H, Bergman A.

J Appl Clin Med Phys. 2018 Nov;19(6):341-345. doi: 10.1002/acm2.12481. Epub 2018 Oct 29.

34.

Concurrent Radiotherapy and Panitumumab after Lymph Node Dissection and Induction Chemotherapy for Invasive Bladder Cancer.

Fransen van de Putte EE, Pos F, Doodeman B, van Rhijn BWG, van der Laan E, Nederlof P, van der Heijden MS, Bloos-van der Hulst J, Sanders J, Broeks A, Kerst JM, van der Noort V, Horenblas S, Bergman AM.

J Urol. 2019 Mar;201(3):478-485. doi: 10.1016/j.juro.2018.10.007.

PMID:
30321552
35.

Anomalous Phonon Lifetime Shortening in Paramagnetic CrN Caused by Spin-Lattice Coupling: A Combined Spin and Ab Initio Molecular Dynamics Study.

Stockem I, Bergman A, Glensk A, Hickel T, Körmann F, Grabowski B, Neugebauer J, Alling B.

Phys Rev Lett. 2018 Sep 21;121(12):125902. doi: 10.1103/PhysRevLett.121.125902.

36.

Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5.

Olson R, Liu M, Bergman A, Lam S, Hsu F, Mou B, Berrang T, Mestrovic A, Chng N, Hyde D, Matthews Q, Lund C, Glick D, Pai H, Basran P, Carolan H, Valev B, Lefresene S, Tyldesley S, Schellenberg D.

BMC Cancer. 2018 Oct 4;18(1):954. doi: 10.1186/s12885-018-4859-7.

37.

Impact of age on exposure to oral antiandrogen therapies in clinical practice.

Crombag MBS, van Nuland M, Bergman AM, Rosing H, Schellens JHM, Huitema ADR, Beijnen JH.

Prostate Cancer Prostatic Dis. 2019 Mar;22(1):168-175. doi: 10.1038/s41391-018-0096-z. Epub 2018 Oct 2.

PMID:
30279580
38.

Multiple biomarker responses in caged benthic gastropods Bellamya aeruginosa after in situ exposure to Taihu Lake in China.

Li Q, Wang M, Duan L, Qiu Y, Ma T, Chen L, Breitholtz M, Bergman Å, Zhao J, Hecker M, Wu L.

Environ Sci Eur. 2018;30(1):34. doi: 10.1186/s12302-018-0164-y. Epub 2018 Sep 11.

39.

Brillouin Dynamic Gratings-A Practical Form of Brillouin Enhanced Four Wave Mixing in Waveguides: The First Decade and Beyond.

Bergman A, Tur M.

Sensors (Basel). 2018 Aug 30;18(9). pii: E2863. doi: 10.3390/s18092863. Review.

40.

Exposure-based cognitive behavior therapy for atopic dermatitis: an open trial.

Hedman-Lagerlöf E, Bergman A, Lindefors N, Bradley M.

Cogn Behav Ther. 2019 Jul;48(4):300-310. doi: 10.1080/16506073.2018.1504320. Epub 2018 Sep 7.

PMID:
30192705
41.

Current EU research activities on combined exposure to multiple chemicals.

Bopp SK, Barouki R, Brack W, Dalla Costa S, Dorne JCM, Drakvik PE, Faust M, Karjalainen TK, Kephalopoulos S, van Klaveren J, Kolossa-Gehring M, Kortenkamp A, Lebret E, Lettieri T, Nørager S, Rüegg J, Tarazona JV, Trier X, van de Water B, van Gils J, Bergman Å.

Environ Int. 2018 Nov;120:544-562. doi: 10.1016/j.envint.2018.07.037. Epub 2018 Aug 28. Review.

42.

A majority gate with chiral magnetic solitons.

Koumpouras K, Yudin D, Adelmann C, Bergman A, Eriksson O, Pereiro M.

J Phys Condens Matter. 2018 Sep 19;30(37):375801. doi: 10.1088/1361-648X/aad82f. Epub 2018 Aug 6.

PMID:
30079893
43.

Effects of 10 MV and Flattening-Filter-Free Beams on Peripheral Dose in a Cohort of Pediatric Patients.

Ben Bouchta Y, Goddard K, Petric MP, Bergman AM.

Int J Radiat Oncol Biol Phys. 2018 Dec 1;102(5):1560-1568. doi: 10.1016/j.ijrobp.2018.07.2002. Epub 2018 Jul 31.

PMID:
30071294
44.

The evolutionary dynamics of metabolic protocells.

Pechuan X, Puzio R, Bergman A.

PLoS Comput Biol. 2018 Jul 20;14(7):e1006265. doi: 10.1371/journal.pcbi.1006265. eCollection 2018 Jul.

45.

Highly-coherent stimulated phonon oscillations in a multi-core optical fiber.

Diamandi HH, London Y, Bashan G, Bergman A, Zadok A.

Sci Rep. 2018 Jun 22;8(1):9514. doi: 10.1038/s41598-018-27929-6.

46.

Efficacy and safety of the glucagon receptor antagonist PF-06291874: A 12-week, randomized, dose-response study in patients with type 2 diabetes mellitus on background metformin therapy.

Kazierad DJ, Chidsey K, Somayaji VR, Bergman AJ, Calle RA.

Diabetes Obes Metab. 2018 Nov;20(11):2608-2616. doi: 10.1111/dom.13440. Epub 2018 Jul 30.

PMID:
29923286
47.

Daily intake of phthalates, MEHP, and DINCH by ingestion and inhalation.

Weiss JM, Gustafsson Å, Gerde P, Bergman Å, Lindh CH, Krais AM.

Chemosphere. 2018 Oct;208:40-49. doi: 10.1016/j.chemosphere.2018.05.094. Epub 2018 May 17.

48.

Loss of androgen receptor signaling in prostate cancer-associated fibroblasts (CAFs) promotes CCL2- and CXCL8-mediated cancer cell migration.

Cioni B, Nevedomskaya E, Melis MHM, van Burgsteden J, Stelloo S, Hodel E, Spinozzi D, de Jong J, van der Poel H, de Boer JP, Wessels LFA, Zwart W, Bergman AM.

Mol Oncol. 2018 Aug;12(8):1308-1323. doi: 10.1002/1878-0261.12327. Epub 2018 Jul 10.

49.

Treatment planning for spinal radiosurgery : A competitive multiplatform benchmark challenge.

Moustakis C, Chan MKH, Kim J, Nilsson J, Bergman A, Bichay TJ, Palazon Cano I, Cilla S, Deodato F, Doro R, Dunst J, Eich HT, Fau P, Fong M, Haverkamp U, Heinze S, Hildebrandt G, Imhoff D, de Klerck E, Köhn J, Lambrecht U, Loutfi-Krauss B, Ebrahimi F, Masi L, Mayville AH, Mestrovic A, Milder M, Morganti AG, Rades D, Ramm U, Rödel C, Siebert FA, den Toom W, Wang L, Wurster S, Schweikard A, Soltys SG, Ryu S, Blanck O.

Strahlenther Onkol. 2018 Sep;194(9):843-854. doi: 10.1007/s00066-018-1314-2. Epub 2018 May 25.

PMID:
29802435
50.

Feasibility and agreement of stiffness measurements using gradient-echo and spin-echo MR elastography sequences in unselected patients undergoing liver MRI.

Cunha GM, Glaser KJ, Bergman A, Luz RP, de Figueiredo EH, Lobo Lopes FPP.

Br J Radiol. 2018 Jul;91(1087):20180126. doi: 10.1259/bjr.20180126. Epub 2018 May 17.

Supplemental Content

Loading ...
Support Center